We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+11.77%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.8B
AUM Growth
-$40.1M
Cap. Flow
-$460M
Cap. Flow %
-7.92%
Top 10 Hldgs %
24.55%
Holding
197
New
37
Increased
72
Reduced
55
Closed
17

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$46.7M
2
IRTC icon
iRhythm Holdings
IRTC
+$37M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$35.8M
4
ENTG icon
Entegris
ENTG
+$21.4M
5
GLBE icon
Global E Online
GLBE
+$20.4M

Top Sells

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$70.1M
2
TT icon
Trane Technologies
TT
+$69.4M
3
DDOG icon
Datadog
DDOG
+$63.8M
4
ARGX icon
argenx
ARGX
+$56M
5
GTLB icon
GitLab
GTLB
+$46.9M

Sector Composition

Rank Sector Weight
1 Healthcare 40.6%
2 Technology 18.78%
3 Industrials 17.39%
4 Consumer Discretionary 9.97%
5 Financials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONTO icon
176
Onto Innovation
ONTO
$12.5B
$1.06M 0.02%
+5,125
New +$1.03M
BSX icon
177
Boston Scientific
BSX
$68.4B
$734K 0.01%
+8,755
New +$690K
MKTX icon
178
MarketAxess Holdings
MKTX
$5.78B
$568K 0.01%
+2,217
New +$520K
SITM icon
179
SiTime
SITM
$15.8B
$557K 0.01%
+3,249
New +$465K
ACLS icon
180
Axcelis
ACLS
$3.85B
$553K 0.01%
+5,276
New +$617K
APLS
181
DELISTED
Apellis Pharmaceuticals
APLS
– –
-209,794
Closed -$8.05M
ARWR icon
182
Arrowhead Research
ARWR
$12.3B
– –
-463,894
Closed -$12.1M
DV icon
183
DoubleVerify
DV
$1.69B
– –
-1,309,820
Closed -$25.5M
FIVN icon
184
CALL
FIVE9
FIVN
$2.12B
– –
-32,000
Closed -$2.24K
FIVN icon
185
FIVE9
FIVN
$2.12B
– –
-579,618
Closed -$25.6M
FSLR icon
186
First Solar
FSLR
$22.1B
– –
-55,399
Closed -$12.5M
MBLY icon
187
Mobileye
MBLY
$1.99B
– –
-673,406
Closed -$18.9M
MDB icon
188
MongoDB
MDB
$26.2B
– –
-9,432
Closed -$2.36M
MU icon
189
Micron Technology
MU
$988B
– –
-8,513
Closed -$1.12M
NXT icon
190
Nextpower Inc
NXT
$14.7B
– –
-781,302
Closed -$36.6M
NYAX
191
Nayax
NYAX
$2.49B
– –
-87,554
Closed -$1.87M
RELY icon
192
Remitly
RELY
$4.94B
– –
-1,267,115
Closed -$15.4M
SYY icon
193
Sysco
SYY
$40.6B
– –
-120,789
Closed -$8.62M
TSBX
194
DELISTED
Turnstone Biologics
TSBX
– –
-458,317
Closed -$1.2M
TSM icon
195
TSMC
TSM
$2.09T
– –
-24,749
Closed -$4.3M
MGX icon
196
Metagenomi Therapeutics
MGX
$45.9M
– –
-583,041
Closed -$2.38M
CERE
197
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-490,000
Closed -$20M
4 5 6 7
8

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Eventide Asset Management held 197 positions worth $5.8B, down 0.69% from $5.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management withdrew a net $460M in Q3 2024, closing 17 positions and reducing 55 holdings. Its most notable exit was Nextpower Inc, an estimated $36.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Relay Therapeutics worth $19M.

  • Eventide Asset Management's largest Q3 2024 buy was Relay Therapeutics: 2,682,083 shares worth $19M.
  • Eventide Asset Management added most to Verona Pharma in Q3 2024, an estimated $46.7M increase.
  • Eventide Asset Management's biggest Q3 2024 reduction was Transmedics, cutting an estimated $70.1M.
  • Eventide Asset Management fully exited Nextpower Inc in Q3 2024, selling an estimated $36.6M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.8B portfolio in Q3 2024.
  • Eventide Asset Management opened 37 new positions and closed 17 in Q3 2024.
  • Eventide Asset Management's portfolio value fell 0.69% quarter-over-quarter to $5.8B.

Based on Eventide Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.